The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse. | AHRQ Patient Safety Network

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse. | AHRQ Patient Safety Network

• Book/Report
 
• Published February 2018

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse.

Washington, DC: America's Health Insurance Plans; 2018.

Guidelines provide practitioners with evidence-based solutions. This report outlines use of a measure to assess adherence to six of the recommendations in the Centers for Disease Control and Prevention guideline for opioid prescribing in primary care.

Free full text (PDF)Related website

Related Resources

BOOK/REPORT

Prescription Opioids: Medicare Needs to Expand Oversight Efforts to Reduce the Risk of Harm.

Washington, DC: United States Government Accountability Office; October 2017. Publication GAO-18-15.

JOURNAL ARTICLE › COMMENTARY

Leadership oversight for patient safety programs: an essential element.

Moffatt-Bruce S, Clark S, DiMaio M, Fann J. Ann Thorac Surg. 2018;105:351-356.

BOOK/REPORT

Improved Policies and Oversight Needed for Reviewing and Reporting Providers for Quality and Safety Concerns.

Washington, DC: United States Government Accountability Office; November 2017. Publication GAO-18-63.

JOURNAL ARTICLE › COMMENTARY

The high costs of unnecessary care.

Carroll AE. JAMA. 2017;318:1748-1749.

JOURNAL ARTICLE › COMMENTARY

Time for transparent standards in quality reporting by health care organizations.

Pronovost PJ, Wu AW, Austin JM. JAMA. 2017;318:701-702.

View More